110 related articles for article (PubMed ID: 10604750)
1. Glycolipid markers of astrocytomas and oligodendrogliomas.
Yates AJ; Comas T; Scheithauer BW; Burger PC; Pearl DK
J Neuropathol Exp Neurol; 1999 Dec; 58(12):1250-62. PubMed ID: 10604750
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers that identify human astrocytomas and oligodendrogliomas.
Popko B; Pearl DK; Walker DM; Comas TC; Baerwald KD; Burger PC; Scheithauer BW; Yates AJ
J Neuropathol Exp Neurol; 2002 Apr; 61(4):329-38. PubMed ID: 11939588
[TBL] [Abstract][Full Text] [Related]
3. Neutral glycolipid composition of primary human brain tumors.
Singh LP; Pearl DK; Franklin TK; Spring PM; Scheithauer BW; Coons SW; Johnson PC; Pfeiffer SE; Li J; Knott JC
Mol Chem Neuropathol; 1994; 21(2-3):241-57. PubMed ID: 8086036
[TBL] [Abstract][Full Text] [Related]
4. Membrane lipids modifications in human gliomas of different degree of malignancy.
Campanella R
J Neurosurg Sci; 1992; 36(1):11-25. PubMed ID: 1323645
[TBL] [Abstract][Full Text] [Related]
5. Glycolipids and myelin proteins in human oligodendrogliomas.
Sung CC; Collins R; Li J; Pearl DK; Coons SW; Scheithauer BW; Johnson PC; Yates AJ
Glycoconj J; 1996 Jun; 13(3):433-43. PubMed ID: 8781974
[TBL] [Abstract][Full Text] [Related]
6. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors.
Sung CC; Pearl DK; Coons SW; Scheithauer BW; Johnson PC; Yates AJ
Cancer; 1994 Dec; 74(11):3010-22. PubMed ID: 7954264
[TBL] [Abstract][Full Text] [Related]
7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
8. ADAM 12: a putative marker of oligodendrogliomas?
Kanakis D; Lendeckel U; Theodosiou P; Dobrowolny H; Mawrin C; Keilhoff G; Bukowska A; Dietzmann K; Bogerts B; Bernstein HG
Dis Markers; 2013; 34(2):81-91. PubMed ID: 23324579
[TBL] [Abstract][Full Text] [Related]
9. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.
Zhuang Z; Qi M; Li J; Okamoto H; Xu DS; Iyer RR; Lu J; Yang C; Weil RJ; Vortmeyer A; Lonser RR
J Neurosurg; 2011 Oct; 115(4):789-95. PubMed ID: 21682567
[TBL] [Abstract][Full Text] [Related]
11. p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma.
Barresi V; Mondello S; Branca G; Rajan TS; Vitarelli E; Tuccari G
Hum Pathol; 2015 Feb; 46(2):231-8. PubMed ID: 25476123
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of immune defense genes in pilocytic astrocytomas.
Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
[TBL] [Abstract][Full Text] [Related]
13. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
[TBL] [Abstract][Full Text] [Related]
14. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors.
Karjalainen SL; Haapasalo HK; Aspatwar A; Barker H; Parkkila S; Haapasalo JA
BMC Cancer; 2018 May; 18(1):584. PubMed ID: 29792187
[TBL] [Abstract][Full Text] [Related]
17. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
Decaestecker C; Lopes BS; Gordower L; Camby I; Cras P; Martin JJ; Kiss R; VandenBerg SR; Salmon I
J Neuropathol Exp Neurol; 1997 Apr; 56(4):391-402. PubMed ID: 9100670
[TBL] [Abstract][Full Text] [Related]
18. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors.
Comas TC; Tai T; Kimmel D; Scheithauer BW; Burger PC; Pearl DK; Jewell SD; Yates AJ
Neuro Oncol; 1999 Oct; 1(4):261-7. PubMed ID: 11550317
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and prognosis in brain glial tumours.
Batistatou A; Kyzas PA; Goussia A; Arkoumani E; Voulgaris S; Polyzoidis K; Agnantis NJ; Stefanou D
J Neurooncol; 2006 Mar; 77(1):17-23. PubMed ID: 16292491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
